CYP1B1 and prostate cancer: As CYP1B1 can inactivate the prostate cancer dug flutamide (Rochat et al, 2001) and is also induced in breast cancer cells after treatment with docetaxel (Martinez et al, 2008), it may have an important function in the development of resistance to chemotherapy.